Tag: Phase I Trial

mother-and-daughter-brushing-teeth

Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial

Phase 1 study amended after two cohorts show no significant adverse events.
Aquestive's Subingual Epinephrine

Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration

Company presented top level Phase 1 results at #AAAAI2022 meeting.
OpenBiome Fecal Capsules

Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients

Encapsulated stool from non-allergic donors alters the immune system and increases tolerance to peanuts.
BlueWillow Biologics

Intranasal Peanut Allergy Vaccine Takes Step Forward

Company is considering vaccines for multiple food allergies including milk, tree nuts and shellfish.
Child Brushing Teeth

Food Allergy Toothpaste Therapy: Positive News from Ongoing Phase 1 Trial

No significant adverse events in any patient during ongoing Phase 1 trial.
Aquestive AQST-108 Epinephrine Film

Sublingual Emergency Epinephrine Takes Another Step Forward in Phase 1 Study

Aquestive's postage-stamp-sized film is designed to dissolve under the tongue to provide epinephrine.
Harmony Study

Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...

The study is still seeking participants 4-55 years of age.
Aquestive's Subingual Epinephrine

Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine

Company updates the public on status of their candidate drug administered under the tongue.
AQST-108 Phase 1

Emergency Epinephrine Film Begins Phase 1 Clinical Trials

First healthy volunteer dosed in a Phase 1 study of AQST-108 for the treatment of allergic reactions including anaphylaxis.
Research

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.